Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516166 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Brain metastases' returned 44 results - Page 1 of 3

  Sort by   
  Sorted by Rank Top-Bottom

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies  
Jain PharmaBiotech, May 2012, Pages: 345
for CNS disorders Effect of CNS disorders on BBB Autoimmune disorders Brain tumors Primary brain tumors Cerebral metastases Central nervous system injuries Cerebrovascular disease Epilepsy


Drug Delivery in Cancer - Technologies, Markets and Companies  
Jain PharmaBiotech, May 2012, Pages: 638
strategies vary according to the type and location of cancer. Role of drug delivery in the management of cancers of the brain, the bladder, the breast, the ovaries and the prostate are used as examples


Pharmacyclics, Inc. - Product Pipeline Review - H2 2011  
Global Markets Direct, Oct 2011, Pages: 118
Plus Chemotherapy To Treat Recurrent Non-Small Cell Lung Cancer Jun 26, 2003: Pharmacyclics Announces Publication Of Phase III Study Of Xcytrin For Brain Metastases Nov 25, 2008: Pharmacyclics


Neuroradiology Review  
CME Group, Jan 2010
radiologist’s career. Therefore, this activity serves as a comprehensive review of neuroradiology and prepares the participants to tackle imaging of the brain, spine, head and neck, as well as the vascular


Handbook of Neuro-Oncology Neuroimaging  
Elsevier Science and Technology, Nov 2007, Pages: 648
region tumors. Chordomas and skull base tumor. Pediatric brain tumors. Intracranial Metastases. Non-Neoplastic mass lesions of the CNS. Neuroimaging Issues in Assessing Response to Brain Tumor Therapy


InSightec Ltd. - Product Pipeline Analysis  
GlobalData, Oct 2011, Pages: 30
clinical trials in oncology indications like pain palliation of bone metastases, breast cancer, prostate, brain applications, liver tumors and Fertility Enhancement trial. This report is a source for data


Neurological Complications of Systemic Cancer and Antineoplastic Therapy  
Informa Healthcare, July 2010, Pages: 648
brain metastases, spinal cord compression, cerebrovascular events, and leptomeningeal disease, as well as less common complications such as paraneoplastic disorders and neoplastic plexopathy. In addition


European Handbook of Neurological Management, Volume 1, 2nd Edition  
John Wiley and Sons Ltd, Oct 2010, Pages: 584
Status epilepticus (H. Meierkord) 28 Alcohol-related seizures then G 29 Brain metastases (R. Soffietti) 30 Paraneoplastic neurological syndromes (C.A. Vedeler) 31 Nystagmus and oscillopsia (A. Straube) 32


Brain Cancer - Pipeline Review, H1 2012  
Global Markets Direct, Jan 2012, Pages: 183
Announces Further Expansion Of Clincal Sites In Ongoing Brain Cancer Trial Jun 27, 2011: to-BBB Starts Clinical Trial In Patients With Brain Metastases Jun 02, 2011: Stemline Therapeutics Announces


Nanobiotechnology Applications, Markets and Companies  
Jain PharmaBiotech, May 2012, Pages: 754
as imaging agents In vivo imaging using nanoparticles Manganese oxide nanoparticles as contrast agent for brain MRI Nanoparticles vs microparticles for cellular imaging Nanoparticles as contrast agent


Brain Tumors: Practical Guide to Diagnosis and Treatment  
Informa Healthcare, Oct 2006, Pages: 557
Brain Tumors: Practical Guide to Diagnosis and Treatment Emphasizing new and emerging therapies in each chapter, this reference provides essential information for clinicians to provide accurate


Cell Therapy - Technologies, Markets and Companies  
Jain PharmaBiotech, May 2012, Pages: 1015
markers Breast cancer stem cells Role of intestinal stem cells in intestinal polyposis Role of endothelial progenitor cells in tumor angiogenesis Role of cancer stem cells in metastases Therapeutic


DNA Sequencing - Technologies, Markets and Companies  
Jain PharmaBiotech, May 2012, Pages: 309
for assessing resistance to anticancer therapy Sequencing of brain tumors Sequencing of breast cancer BRCA mutations Sequencing of metastases Circulating nucleic acids as biomarkers of cancer Whole genome


International Neurology  
John Wiley and Sons Ltd, Sep 2009, Pages: 728
ependymoma. Non-glial tumors. 134. Nerve sheath tumors. 135. Meningiomas. 136. Medulloblastoma. 137. Primary central nervous system lymphoma (CNSL). Metastatic tumors. 138. Brain metastases. 139


Advances in Nuclear Oncology:: Diagnosis and Therapy  
Informa Healthcare, Oct 2007, Pages: 544
: Therapeutic Applications 18. Differentiated Thyroid Cancer 19. Medullary Thyroid Cancer 20. Lymphoma 21. Neuroendocrine Tumors 22. Bone Metastases 23. Liver Tumors 24. Colorectal Cancer 25. Brain Tumors 26


Textbook of Surgical Oncology  
Informa Healthcare, Nov 2007, Pages: 448
, Rectum and Anus. Pancreatic Cancer and Ampullary Carcinoma. HCC. Carcinoma of the Biliary Tree and Gallbladder. Liver Metastases. UROLOGY. Kidney: Renal Cell Carcinoma. Urothelium. Prostate. Testicular


RNAi - Technologies, Markets and Companies  
Jain PharmaBiotech, May 2012, Pages: 485
and cancer miRNAs and cancer metastases Role of miRNAs in cancer diagnosis Cancer miRNA signature miRNA biomarkers in cancer Diagnostic value of miRNA in cancer Prognostic value of miRNA in cancer mi


Positron Emission Tomography-Computed Tomography: A Disease-Oriented Approach  
Informa Healthcare, March 2008, Pages: 480
in-depth study and PowerPoint slide presentations. Preface. Clinical PET/CT in the brain. PET/CT in GYN Malignancies. Head and Neck Cancer: Evaluation with PET/CT. PET/CT for the evaluation of diseases


Lung Cancer: Translational and Emerging Therapies  
Informa Healthcare, May 2007, Pages: 280
Targeted Therapies in Lung Cancer. Lung Cancer Vaccines. Advances in Chemoradiation Treatment of Locoregionally Advanced Non-Small Cell Lung Cancer. Advances in the Treatment of Brain Metastases. Recent


Peregrine Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011  
Global Markets Direct, Nov 2011, Pages: 126
Of Blood Vessels By Up to 85% in Breast Cancer Tumor Metastases Mar 30, 2004: Peregrine's VTA Inhibits Growth Of Breast Cancer Tumor Metastases By Up To 58 Percent Mar 29, 2004: Peregrine's VTA


Results:  First -   Prev -   1 -   2 -   3 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds